Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ghaliah Aldamegh"'
Autor:
Ohoud Aljuhani, Khalid Al Sulaiman, Ghazwa B. Korayem, Ali F. Altebainawi, Samiah Alsohimi, Rahaf Alqahtani, Saeedah Alfaifi, Aisha Alharbi, Azzah AlKhayrat, Ahmed Hattan, Meshal Albassam, Omar A. Almohammed, Atheer Alkeraidees, Dhay A. Alonazi, Weam F. Alsalman, Ghaliah Aldamegh, Rasha Alshahrani, Ramesh Vishwakarma
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract The use of tocilizumab for the management of COVID-19 emerged since it modulates inflammatory markers by blocking interleukin 6 receptors. Concerns regarding higher thrombosis risk while using tocilizumab were raised in the literature. The a
Externí odkaz:
https://doaj.org/article/9da835e4fbf34006bcb8aac9dd69d3b0
Autor:
Mohammad S. Shawaqfeh, Dalal Alangari, Ghaliah Aldamegh, Jumana Almotairi, Luluh Bin Orayer, Nataleen A. Albekairy, Wesam Abdel-Razaq, Ghada Mardawi, Faisal Almuqbil, Tariq M. Aldebasi, Abdulkareem M. Albekairy
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 11, Pp 101789- (2023)
Background: Medication errors (MEs) are a significant healthcare problem that can harm patients and increase healthcare expenses. Being immunocompromised, liver-transplant patients are at high risk for complications if MEs inflict harmful or damaging
Externí odkaz:
https://doaj.org/article/00fd198aaee341d0a4761451e4a6d794